LOCALIZED OSTEOSARCOMA
Clinical trials for LOCALIZED OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALIZED OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for LOCALIZED OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to improve survival in young bone cancer patients
Disease control Recruiting nowThis study tests whether adding the drug cabozantinib to standard chemotherapy works better than chemo alone for people under 40 with newly diagnosed osteosarcoma, a type of bone cancer. Cabozantinib blocks signals that help tumors grow and form blood vessels. The trial will chec…
Matched conditions: LOCALIZED OSTEOSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New study tracks osteosarcoma treatments in young patients
Knowledge-focused Recruiting nowThis study is observing 120 people up to age 40 with localized osteosarcoma (a bone cancer that hasn't spread). Researchers will collect information on patient characteristics, treatments, and outcomes like cancer recurrence and survival. The goal is to better understand current …
Matched conditions: LOCALIZED OSTEOSARCOMA
Sponsor: Italian Sarcoma Group • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC